JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6026
Hyperfine
HYPR
$92.4M
| $4K | ﹤0.01% |
2,581
| – | – |
2022 Q4
1 quarter
|
|
6027
iShares Morningstar Multi-Asset Income ETF
IYLD
$124M
| $4K | ﹤0.01% |
190
+58
| +44% | +$1.13K |
2020 Q1
12 quarters
|
|
|
JMIA
6028
Jumia Technologies
JMIA
$935M
| $4K | ﹤0.01% |
1,145
-665
| -37% | -$2.39K |
2020 Q2
11 quarters
|
|
6029
Nuveen Multi-Market Income Fund
JMM
$52.8M
| $4K | ﹤0.01% |
+737
| New | +$4.42K |
2023 Q1
0 quarters
|
|
6030
Kaltura
KLTR
$198M
| $4K | ﹤0.01% |
2,014
+1,846
| +1,099% | +$3.63K |
2022 Q4
1 quarter
|
|
|
SEGG
6031
Sports Entertainment Gaming Global Corp
SEGG
$7.3M
| $4K | ﹤0.01% |
9
| – | – |
2020 Q4
9 quarters
|
|
6032
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$95.6M
| $4K | ﹤0.01% |
78
| – | – |
2021 Q4
5 quarters
|
|
6033
Nuveen Taxable Municipal Income Fund
NBB
$414M
| $4K | ﹤0.01% |
+240
| New | +$3.91K |
2023 Q1
0 quarters
|
|
6034
Navios Maritime Partners
NMM
$2.69B
| $4K | ﹤0.01% |
180
| – | – |
2021 Q1
8 quarters
|
|
6035
NextCure
NXTC
$22.7M
| $4K | ﹤0.01% |
244
| – | – |
2019 Q2
15 quarters
|
|
|
OBE
6036
Obsidian Energy
OBE
$693M
| $4K | ﹤0.01% |
613
+510
| +495% | +$3.32K |
2022 Q1
4 quarters
|
|
|
ORBS
6037
Eightco Holdings
ORBS
$473M
| $4K | ﹤0.01% |
218
+169
| +345% | +$8.11K |
2022 Q2
3 quarters
|
|
6038
Olema Pharmaceuticals
OLMA
$692M
| $4K | ﹤0.01% |
1,194
| – | – |
2020 Q4
9 quarters
|
|
6039
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.61B
| $4K | ﹤0.01% |
+50
| New | +$3.74K |
2023 Q1
0 quarters
|
|
6040
Satellogic
SATL
$821M
| $4K | ﹤0.01% |
1,700
| – | – |
2022 Q3
2 quarters
|
|
6041
Sera Prognostics
SERA
$82.4M
| $4K | ﹤0.01% |
959
| – | – |
2021 Q3
6 quarters
|
|
6042
Global X Social Media ETF
SOCL
$85.4M
| $4K | ﹤0.01% |
+110
| New | +$3.9K |
2023 Q1
0 quarters
|
|
6043
Shattuck Labs
STTK
$656M
| $4K | ﹤0.01% |
1,426
| – | – |
2020 Q4
9 quarters
|
|
6044
Energous
WATT
$70.3M
| $4K | ﹤0.01% |
13
+4
| +44% | +$1.7K |
2021 Q1
8 quarters
|
|
6045
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$6.73M
| $4K | ﹤0.01% |
+20
| New | +$5.01K |
2023 Q1
0 quarters
|
|
6046
Woori Financial
WF
$18.6B
| $4K | ﹤0.01% |
142
-5,631
| -98% | -$161K |
2015 Q4
29 quarters
|
|
|
XNET
6047
Xunlei
XNET
$303M
| $4K | ﹤0.01% |
2,287
+1,925
| +532% | +$3.79K |
2020 Q1
12 quarters
|
|
6048
ProShares UltraShort Silver
ZSL
$72.4M
| $4K | ﹤0.01% |
6
-40
| -87% | -$35K |
2022 Q3
2 quarters
|
|
6049
Zevra Therapeutics
ZVRA
$605M
| $4K | ﹤0.01% |
778
| – | – |
2021 Q2
7 quarters
|
|
|
LENZ
6050
LENZ Therapeutics
LENZ
$109M
| $4K | ﹤0.01% |
210
-349
| -62% | -$5.64K |
2021 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.